======= LMO4 ======= == Gene Information == * **Official Symbol**: LMO4 * **Official Name**: LIM domain only 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8543|8543]] * **UniProt**: [[https://www.uniprot.org/uniprot/P61968|P61968]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LMO4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LMO4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603129|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Probable transcriptional factor. {ECO:0000250}. |LIM| |regulation of cell fate specification| |spinal cord association neuron differentiation| |ventral spinal cord interneuron differentiation| |dorsal spinal cord development| |enhancer sequence-specific DNA binding| |regulation of cell fate commitment| |spinal cord motor neuron differentiation| |cell leading edge| |thymus development| |ventral spinal cord development| |cell differentiation in spinal cord| |ventricular septum development| |neural tube closure| |tube closure| |primary neural tube formation| |neural tube formation| |spinal cord development| |cardiac septum development| |embryonic epithelial tube formation| |cardiac ventricle development| |negative regulation of protein complex assembly| |epithelial tube formation| |morphogenesis of embryonic epithelium| |tube formation| |neural tube development| |cardiac chamber development| |central nervous system neuron differentiation| |transcription factor complex| |epithelial tube morphogenesis| |transcription factor binding| |gland development| |morphogenesis of an epithelium| |regulation of protein complex assembly| |transcription by RNA polymerase II| |heart development| |tissue morphogenesis| |embryonic morphogenesis| |positive regulation of kinase activity| |hematopoietic or lymphoid organ development| |chordate embryonic development| |regulation of cell activation| |transcription, DNA-templated| |nucleic acid-templated transcription| |immune system development| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |tube morphogenesis| |positive regulation of transferase activity| |DNA-binding transcription factor activity| |negative regulation of cellular component organization| |tube development| |regulation of cell migration| |circulatory system development| |regulation of kinase activity| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |regulation of cellular component biogenesis| |embryo development| |regulation of transferase activity| |central nervous system development| |regulation of locomotion| |regulation of cellular component movement| |neuron differentiation| |positive regulation of phosphorylation| |nucleobase-containing compound biosynthetic process| |epithelium development| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |organic cyclic compound biosynthetic process| |positive regulation of catalytic activity| |generation of neurons| |positive regulation of transcription, DNA-templated| |regulation of phosphorylation| |neurogenesis| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.73| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.31| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.406| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15624 * **Expression level (log2 read counts)**: 4.86 {{:chemogenomics:nalm6 dist.png?nolink |}}